Geoffrey L. Uy - Publications, H-index & Citations

Geoffrey L. Uy

Washington University School of Medicine

57H指数

463论文数

1.4W被引数

收录论文 100

发表时间

Oral Azacitidine Maintenance After CPX-351 in Transplant-Ineligible Patients With Therapy-Related or Myelodysplasia-Related Acute Myeloid Leukemia 在移植不适宜的继发性或骨髓增生异常综合征相关急性髓系白血病患者中，CPX-351治疗后口服阿扎胞苷维持治疗

American Journal of Hematology

IF9.9

2026-10-12

OAAI

Caroline Fileni; Edmond Chiche; David Swoboda; Alexander Coltoff; Rami Komrokji; Geoffrey Uy; Sarah Bertoli; Lenaig Le Clech; Mael Heiblig; Ludovic Gabellier; Patrick Lawrence; Lydia Kretschmer; Christoph Röllig; A. H. Wei; Fabio Guolo; Roberto Massimo Lemoli; Jeffrey Lancet; David Sallman; Thomas Cluzeau

Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS)基于低甲基化制剂治疗的反应对高风险骨髓增生异常综合征/肿瘤患者生存结局的影响：考虑基线临床-分子风险和移植状态的国际骨髓增生异常综合征联盟(icMDS)分析

American Journal of Hematology

IF9.9

2026-08-28

PREAI

Benjamin Rolles; Jan Philipp Bewersdorf; Tariq Kewan; Ondrej Blaha; Jessica M. Stempel; Luca Lanino; Najla H. Al Ali; Amy E. DeZern; Mikkael A. Sekeres; Geoffrey L. Uy; Samuel Urrutia; Hetty E. Carraway; Pinkal Desai; Elizabeth A. Griffiths; Eytan M. Stein; Andrew M. Brunner; Christine McMahon; Rory M. Shallis; Joshua F. Zeidner; Michael R. Savona; Shougat Barua; Namrata Sonia Chandhok; Constantine Logothetis; Aram Bidikian; Ted M. Getz; Gail J. Roboz; Eunice S. Wang; Amyah C. Harris; Maria L. Amaya; Hayley Hawkins; Somedeb Ball; Justin Grenet; Parisa Abedi; Shai Shimony; R. Coleman Lindsley; Zhuoer Xie; Yazan F. Madanat; Yasmin Abaza; Talha Badar; Torsten Haferlach; Jaroslaw P. Maciejewski; David Sallman; Anoop Enjeti; Kamal Al-Rabi; Khalid Halahleh; Devendra Hiwase; Maria Diez-Campelo; David Valcarcel; Claudia Haferlach; Lisa Pleyer; Ioannis Kotsianidis; Vasiliki Pappa; Valeria Santini; Angela Consagra; Aref Al-Kali; Seishi Ogawa; Yasuhito Nannya; Matteo Giovanni Della Porta; Rami S. Komrokji; Amer M. Zeidan; Maximilian Stahl

Decentralized Clinical Trials in Hematology: the Promise and the Peril 血液学中的去中心化临床试验：前景与风险

Blood

IF23.1

2026-07-08

PREAI

Giulia Petrone; Geoffrey L. Uy; Kelly L. Bolton

Prognostic and therapeutic implications of BRAF mutations in acute myeloid leukemia BRAF突变在急性髓系白血病中的预后和治疗意义

Leukemia

IF13.4

2026-06-15

OAAI

Darren Lee; Yazan Abu-Shihab; Kate Plas; Deedra Nicolet; Krzysztof Mrózek; Mark J. Routbort; Keyur P. Patel; Christopher J. Walker; Jill Buss; Andrew R. Stiff; Andrea Laganson; Courtney D. DiNardo; Naval G. Daver; Tapan M. Kadia; Farhad Ravandi; Andrew J. Carroll; Jonathan E. Kolitz; Bayard L. Powell; William G. Blum; Maria R. Baer; Guido Marcucci; Geoffrey L. Uy; Wendy Stock; Richard M. Stone; L. Jeffrey Medeiros; John C. Byrd; James S. Blachly; Robert L. Bowman; Jeffrey W. Tyner; Sanam Loghavi; Ann-Kathrin Eisfeld; Linde A. Miles

Correction: CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysis 更正：CPX-351与常规化疗的心脏毒性比较：高风险AML的III期试验事后分析

Cardio-Oncology

IF3.2

2026-05-23

OAAI

Joshua D. Mitchell; Michael Pfeiffer; John Boehmer; John Gorcsan; Shunsuke Eguchi; Yoshiyuki Orihara; Nalina Dronamraju; Sonja Dhani; Stefan Faderl; Tara L. Lin; Geoffrey L. Uy; Jeffrey E. Lancet; Jorge E. Cortes

Long-term Follow-up of a Pediatric Regimen for AYA with Ph-negative ALL: 10-year Survival of CALGB 10403 (Alliance)AYA伴Ph阴性ALL的儿科方案长期随访：CALGB 10403 (Alliance) 10年生存率

Blood Advances

IF7.1

2026-05-12

OAAI

Wellington F. Silva; Jun Yin; Michaela Liedtke; David F. Claxton; Noreen Fulton; Sharmila Giri; Gregory Malnassy; Krzysztof Mrózek; Elisabeth Paietta; Charles G. Mullighan; Ilene Galinsky; Jeffrey A. Bogart; John C. Grecula; LeAnne Kennedy; Richard A. Larson; Richard M Stone; Geoffrey L. Uy; Selina M. Luger; Anjali S. Advani; Wendy Stock

CPX-351 Selectively Benefits Patients with AML and Myelodysplasia-Related Mutations in the Pivotal Randomized Trial 在关键性随机试验中，CPX-351选择性地使AML和脊髓发育不良相关突变患者受益

Blood Advances

IF7.1

2026-02-04

OAAI

Shai Shimony; H. Moses Murdock; Julia Keating; Harrison K. Tsai; Archana Sasi; Christopher J. Gibson; Stefan Faderl; Anthony Wagner; Nalina Dronamraju; Tara L. Lin; Thomas Prebet; Jorge E. Cortes; Geoffrey L. Uy; Jeffrey E. Lancet; Christopher R. Reilly; Donna Neuberg; Richard M. Stone; R. Coleman Lindsley

Synthetic lethality of decitabine plus ATR inhibition for TP53-mutated AML

Blood Advances

IF7.1

2026-02-02

OAAI

Jeremy T. Baeten; Sumedha Agashe; Imene Tabet; Jack T. Wooldridge; Amber Carter; Jamie N. Butler; Christopher A Miller; Nicole Helton; Annabel Quinet; Kimberly B. Johansson; Yichan Yang; Geoffrey L. Uy; Alessandro Vindigni; Daniel C. Link

CPX-351 vs. conventional chemotherapy cardiotoxicity in high-risk AML: a post hoc phase III trial analysis CPX-351与常规化疗的心脏毒性比较：高风险AML的III期试验事后分析

Cardio-Oncology

IF3.2

2025-11-25

OAAI

A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate E-Selectin Inhibition with Uproleselan to Reduce GI Toxicity During Autologous Hematopoietic Cell Transplantation for Multiple Myeloma 一项评估Uproleselan抑制E-选择素以减少多发性骨髓瘤自体造血细胞移植期间胃肠道毒性的II期随机、双盲、安慰剂对照试验

Transplantation and Cellular Therapy

IF4.4

2025-11-09

PREAI

Zachary D. Crees; Keith Stockerl-Goldstein; Meaghan Ryan; Feng Gao; Brandon Christen; Chris Mayeski; Michael J. Slade; Mark A. Schroeder; Ravi Vij; John F. DiPersio; Geoffrey L. Uy

Early assessment of treatment response in AML using FLT PET/cT: a trial of the ECOG-ACRIN Cancer Research Group (EAI141)使用FLT PET/cT对AML的早期治疗反应评估：ECOG-ACRIN癌症研究组（EAI141）试验

LEUKEMIA & LYMPHOMA

IF2.2

2025-11-01

PREAI

Jeraj, Robert; Duan, Fenghai; Mattison, Ryan J.; Romanoff, Justin; Kostakoglu, Lale; Arber, Daniel A.; Paietta, Elisabeth M.; Holter-Chakrabarty, Jennifer L.; Arnold, Charles D.; Strickland, Stephen A.; Whisenant, Jennifer G.; Siegel, Barry A.; Uy, Geoffrey L.; Begna, Kebede H.; Wiseman, Gregory A.; Hall, Aric C.; Perlman, Scott B.; Litzow, Mark R.; Mankoff, David A.

Genomic and immunogenomic profiling of extramedullary acute myeloid leukemia reveals actionable clonal branching and frequent immune editing 外显性急性髓系白血病的基因组及免疫基因组分析揭示了可操作性的克隆分支和频繁的免疫编辑

Blood Cancer Journal

IF11.6

2025-08-13

OAAI

Clément Collignon; Tucker Hansen; Colin Hercus; Marianna B. Ruzinova; Gabrielle Roth Guepin; Caroline Bonmati; Marie Thérèse Rubio; Pierre Feugier; Mélanie Gaudfrin; Hervé Sartelet; Marion Divoux; Marc Muller; Sharon Heath; Geoffrey L. Uy; David H. Spencer; David Y. Chen; Simona Pagliuca; Francesca Ferraro

Impact of transplant conditioning, NPM1 mutations, and measurable residual disease in FLT3-ITD acute myeloid leukemia 移植预处理、NPM1突变及FLT3-ITD急性髓系白血病中可测量的微小残留病的影响

Blood Advances

IF7.1

2025-07-03

OAAI

Mark J. Levis; Mehdi Hamadani; Brent R. Logan; Richard J. Jones; Anurag K. Singh; Mark R. Litzow; John R. Wingard; Esperanza B. Papadopoulos; Alexander E. Perl; Robert J. Soiffer; Celalettin Ustun; Masumi Ueda Oshima; Geoffrey L. Uy; Edmund K. Waller; Sumithira Vasu; Melhem Solh; Asmita Mishra; Lori S. Muffly; Hee-Je Kim; Matthias Stelljes; Yuho Najima; Masahiro Onozawa; Kirsty Thomson; Caroline Chen; Nahla Hasabou; Matt Rosales; Jason E. Hill; Stanley C. Gill; Rishita Nuthethi; Denise King; Adam Mendizabal; Steven M. Devine; Mary M. Horowitz; Yi-Bin Chen

Results of Cancer and Leukemia Group B 10102 (Alliance), a Phase 1/2 Study

CANCER

IF5.1

2025-02-06

OAAI

Luskin, Marlise R.; Yin, Jun; Lozanski, Gerard; Curran, Emily; Malnassy, Gregory; Mrozek, Krzysztof; Bloomfield, Clara D.; Cataland, Spero R.; Fulton, Noreen; Kolitz, Jonathan; Laplant, Betsy; Kour, Oudom; Powell, Bayard L.; Vij, Ravi; Wang, Eunice S.; Grinblatt, David; Stone, Richard M.; Uy, Geoffrey L.; Larson, Richard A.; Stock, Wendy

Lower-intensity CPX-351 plus venetoclax induction for adults with newly diagnosed AML unfit for intensive chemotherapy

BLOOD ADVANCES

IF7.1

2024-12-13

OAAI

Uy, Geoffrey L.; Pullarkat, Vinod; Baratam, Praneeth; Stuart, Robert K.; Walter, Roland B.; Winer, Eric S.; Wang, Qi; Faderl, Stefan; Chakravarthy, Divya; Menno, Diane; Cheung, Ronald S.; Lin, Tara L.

Efficacy and Safety of Pembrolizumab Added to Azacitidine Plus Venetoclax for Patients with Acute Myeloid Leukemia: Results from an Investigator-Initiated, Multi-Center, CTEP-Sponsored Randomized, Phase II Trial (BLAST AML-2)培美曲塞联合阿扎胞苷和维奈克拉用于急性髓系白血病患者的疗效与安全性：一项研究者发起、多中心、CTEP资助的随机、Ⅱ期试验（BLAST AML-2）的结果

BLOOD

IF23.1

2024-11-05

PREAI

Stempel, Jessica M.; Uy, Geoffrey L.; Dinner, Shira N.; Gojo, Ivana; Reed, Daniel; Roy, Rupali; Byrd, Kenneth P.; Yerrabothala, Swaroopa; Lai, Catherine E.; Doucette, Kimberley; Caldwell, Anne; Blaha, Ondrej; Podoltsev, Nikolai A.; Mendez, Lourdes M.; Bewersdorf, Jan Philipp; Kewan, Tariq; Wistuba, Ignacio; Alatrash, Gheath; Haymaker, Cara L.; Streicher, Howard; Sharon, Elad; Mph, Richard Little M. D.; Gore, Steven D.; Radich, Jerald P.; Mdphd, Brent L. Wood; Zeidan, Amer M.; Shallis, Rory M.

Clearance of Leukemia Associated Mutations (LAMs) after Induction Therapy Is Associated with Favorable Outcomes in Intermediate Risk Acute Myeloid Leukemia: Interim Results of a Multicenter, Prospective Phase II Trial 白血病相关突变（LAMs）在诱导治疗后清除与中危急性髓系白血病的不良预后相关：一项多中心、前瞻性II期试验的 interim 结果

BLOOD

IF23.1

2024-11-05

PREAI

Jacoby, Meagan; Spencer, David H.; Uy, Geoffrey L.; Gao, Feng; Burton, Tasha; Heath, Sharon E.; Du, Feiyu; O'Laughlin, Shelly; Fulton, Robert; Al-Mansour, Zeina A.; Cogle, Christopher R.; Huselton, Eric J.; Dipersio, John F.; Westervelt, Peter; Schroeder, Mark A.; Ghobadi, Armin; Pusic, Iskra; Stockerl-Goldstein, Keith; Kahl, Brad S.; Cashen, Amanda F.; Christopher, Matt; Singh, Nathan; Vij, Ravi; Crees, Zachary D.; Day, Ryan B.; Fehniger, Todd; Oetjen, Karolyn; Patel, Dilan A.; Kim, Miriam Y.; Slade, Michael; Link, Daniel C.; Walter, Matthew J.; Abboud, Camille N.; Abboud, Ramzi; Ley, Timothy J.

DNA Hypomethylation Is Not Sufficient to Account for Decitabine Mediated Cytotoxicity in TP53-Mutated Myeloid Malignancies DNA低甲基化不足以解释地西他滨介导的TP53突变髓系恶性疾病的细胞毒性

BLOOD

IF23.1

2024-11-05

PREAI

Baeten, Jeremy T.; Agashe, Sumedha; Quinet, Annabel; Butler, Jamie; Carter, Amber C.; Wooldridge, Jack; Johansson, Kimberly; Uy, Geoffrey L.; Vindigni, Alessandro; Link, Daniel C.

Improving risk stratification for 2022 European LeukemiaNet favorable- risk patients with acute myeloid leukemia

INNOVATION

IF25.7

2024-11-01

OAAI

Archer, Kellie J.; Fu, Han; Mrozek, Krzysztof; Nicolet, Deedra; Mims, Alice S.; Uy, Geoffrey L.; Stock, Wendy; Byrd, John C.; Hiddemann, Wolfgang; Metzeler, Klaus H.; Rausch, Christian; Krug, Utz; Sauerland, Cristina; Goerlich, Dennis; Berdel, Wolfgang E.; Woermann, Bernhard J.; Braess, Jan; Spiekermann, Karsten; Herold, Tobias; Eisfeld, Ann-Kathrin

Monitoring clonal burden as an alternative to blast count for myelodysplastic neoplasm treatment response

LEUKEMIA

IF13.4

2024-10-04

PREAI

Jacoby, Meagan A.; Duncavage, Eric D.; Khanna, Ajay; Chang, Gue Su; Srivatsan, Sridhar Nonavinkere; Miller, Christopher A.; Gao, Feng; Robinson, Josh; Shao, Jin; Fulton, Robert S.; Fronick, Catrina C.; O'Laughlin, Michelle; Heath, Sharon E.; Brendel, Kimberly; Chavez, Monique; Dipersio, John F.; Abboud, Camille N.; Stockerl-Goldstein, Keith; Westervelt, Peter; Cashen, Amanda; Pusic, Iskra; Oh, Stephen T.; Welch, John S.; Wells, Denise A.; Loken, Michael R.; Uy, Geoffrey L.; Walter, Matthew J.

研究方向